1. Home
  2. DEI vs PVLA Comparison

DEI vs PVLA Comparison

Compare DEI & PVLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Douglas Emmett Inc.

DEI

Douglas Emmett Inc.

HOLD

Current Price

$11.07

Market Cap

1.8B

Sector

Real Estate

ML Signal

HOLD

Logo Palvella Therapeutics Inc.

PVLA

Palvella Therapeutics Inc.

HOLD

Current Price

$128.42

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DEI
PVLA
Founded
1971
2015
Country
United States
United States
Employees
N/A
14
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.6B
IPO Year
2006
N/A

Fundamental Metrics

Financial Performance
Metric
DEI
PVLA
Price
$11.07
$128.42
Analyst Decision
Hold
Strong Buy
Analyst Count
8
15
Target Price
$12.94
$171.87
AVG Volume (30 Days)
2.0M
202.0K
Earning Date
05-05-2026
05-14-2026
Dividend Yield
6.83%
N/A
EPS Growth
N/A
N/A
EPS
0.09
N/A
Revenue
$1,003,982,000.00
N/A
Revenue This Year
$1.70
N/A
Revenue Next Year
$2.35
$104,350.18
P/E Ratio
$123.61
N/A
Revenue Growth
1.77
N/A
52 Week Low
$9.04
$20.20
52 Week High
$16.94
$151.18

Technical Indicators

Market Signals
Indicator
DEI
PVLA
Relative Strength Index (RSI) 71.28 53.98
Support Level $10.85 $108.99
Resistance Level $11.22 $133.53
Average True Range (ATR) 0.33 7.01
MACD 0.13 -0.40
Stochastic Oscillator 97.03 43.18

Price Performance

Historical Comparison
DEI
PVLA

About DEI Douglas Emmett Inc.

Douglas Emmett Inc is an integrated, self-administered, and self-managed REIT. The group focuses on owning, acquiring, developing, and managing a substantial market share of office properties and multifamily communities in neighborhoods with supply constraints, high-end executive housing, and key lifestyle amenities. Its properties are located in the Beverly Hills, Brentwood, Burbank, Century City, Olympic Corridor, Santa Monica, Sherman Oaks/Encino, Warner Center/Woodland Hills and Westwood submarkets of Los Angeles County, California, and in Honolulu, Hawaii. It has two business segments: the office segment and multifamily segment, of which Office segment derives maximum revenue.

About PVLA Palvella Therapeutics Inc.

Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company's lead product candidate, QTORIN 3.9 percent rapamycin anhydrous gel (QTORIN rapamycin), is based on the Company's patented QTORIN platform. QTORIN rapamycin is in clinical development for two rare genetic skin disorders.

Share on Social Networks: